Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus

Vaccine

Volumn 33, Issue 22, 2015, Pages 2602-2605

  Brinth, Louise S ^a   Pors, Kirsten ^a   Theibel, Ann C ^a   Mehlsen, Jesper ^a  

^a FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

Autonomic nervous system; Human papilloma virus vaccination

Indexed keywords

BILIRUBIN; WART VIRUS VACCINE;

ABDOMINAL PAIN; ACNE; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; COGNITIVE DEFECT; DIZZINESS; FAINTNESS; FATIGUE; FEMALE; FEVER; HEADACHE; HEART PALPITATION; HEART RATE; HUMAN; LIMIT OF DETECTION; MALAISE; MUSCLE WEAKNESS; MYOCLONUS; NAUSEA; NEUROPATHIC PAIN; ORTHOSTATIC INTOLERANCE; PAPILLOMAVIRUS INFECTION; PHYSICAL ACTIVITY; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PREVALENCE; PRIORITY JOURNAL; SEGMENTAL DYSTONIA; SINUS TACHYCARDIA; SLEEP DISORDER; SORE THROAT; TREMOR; VACCINATION; ADOLESCENT; BLOOD; CASE REPORT; CHILD; COGNITION DISORDERS; NEURALGIA; QUESTIONNAIRE; YOUNG ADULT;

ADOLESCENT; ADULT; BILIRUBIN; CHILD; COGNITION DISORDERS; FATIGUE; FEMALE; HEADACHE; HEART RATE; HUMANS; NEURALGIA; PAPILLOMAVIRUS VACCINES; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; SURVEYS AND QUESTIONNAIRES; VACCINATION; YOUNG ADULT;

EID: 84928824992     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.03.098     Document Type: Article

References (28)

1. Slade B.A., Leidel L., Vellozzi C., Woo E.J., Hua W., Sutherland A., et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009, 302(Aug (7)):750-757.
2. Arnheim-Dahlstrom L., Pasternak B., Svanstrom H., Sparen P., Hviid A. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ 2013, 347:f5906.
3. Blitshteyn S. Postural tachycardia syndrome following human papillomavirus vaccination. Eur J Neurol 2014, 21(1):135-139.
4. Kinoshita T., Abe R.T., Hineno A., Tsunekawa K., Nakane S., Ikeda S. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine. Intern Med 2014, 53(19):2185-2200.
5. Low P.A., Opfer-Gehrking T.L., Textor S.C., Benarroch E.E., Shen W.K., Schondorf R., et al. Postural tachycardia syndrome (POTS). Neurology 1995, 45(4 (Suppl. 5)):S19-S25.
6. Freeman R., Wieling W., Axelrod F.B., Benditt D.G., Benarroch E., Biaggioni I., et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 2011, 21(Apr (2)):69-72.
7. Grubb B.P. Postural tachycardia syndrome. Circulation 2008, 117(May (21)):2814-2817.
8. Stewart J.M. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res 2000, 48(Aug (2)):218-226.
9. Grubb B.P., Kanjwal Y., Kosinski D.J. The postural tachycardia syndrome: a concise guide to diagnosis and management. J Cardiovasc Electrophysiol 2006, 17(1):108-112.
10. Schondorf R., Low P.A. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia?. Neurology 1993, 43(1):132-137.
11. Wang X.L., Chai Q., Charlesworth M.C., Figueroa J.J., Low P., Shen W.K., et al. Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome. Proteomics Clin Appl 2012, 6(Dec (11-12)):615-625.
12. Li H., Yu X., Liles C., Khan M., Vanderlinde-Wood M., Galloway A., et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc 2014, 3(1):e000755.
13. Sletten D.M., Suarez G.A., Low P.A., Mandrekar J., Singer W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc 2012, 87(12):1196-1201.
14. Suarez G.A., Opfer-Gehrking T.L., Offord K.P., Atkinson E.J., O'Brien P.C., Low P.A. The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology 1999, 52(Feb (3)):523-528.
15. Kurtze N., Rangul V., Hustvedt B.E. Reliability and validity of the international physical activity questionnaire in the Nord-Trondelag health study (HUNT) population of men. BMC Med Res Methodol 2008, 8:63.
16. Nishioka K., Yokota S., Matsumoto Y. Clinical features and preliminary diagnostic criteria of human papillomavirus vaccination associated with neuroimmunopathic syndrome (HANS). Int J Rheum Dis 2014, 17(Suppl. 2):6-29.
17. Perrie Y., Mohammed A.R., Kirby D.J., McNeil S.E., Bramwell V.W. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens. Int J Pharm 2008, 364(Dec (2)):272-280.
18. Partinen M., Saarenpaa-Heikkila O., Ilveskoski I., Hublin C., Linna M., Olsen P., et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE 2012, 7(3):e33723.
19. Streeten D.H., Anderson G.H. Delayed orthostatic intolerance. Arch Intern Med 1992, 152(5):1066-1072.
20. Adamec I., Lovric M., Zaper D., Barusic A.K., Bach I., Junakovic A., et al. Postural orthostatic tachycardia syndrome associated with multiple sclerosis. Auton Neurosci 2013, 173(Jan (1-2)):65-68.
21. Schofield J., Blitshteyn S., Shoenfeld Y., Hughes G. Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS). Lupus 2014, 23(Feb (7)):697-702.
22. Pedersen B.K., Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 2000, 80(Jul (3)):1055-1081.
23. Pascoe A.R., Fiatarone Singh M.A., Edwards K.M. The effects of exercise on vaccination responses: a review of chronic and acute exercise interventions in humans. Brain Behav Immun 2014, 39(Jul):33-41.
24. Basiglio C.L., Arriaga S.M., Pelusa F., Almara A.M., Kapitulnik J., Mottino A.D. Complement activation and disease: protective effects of hyperbilirubinaemia. Clin Sci (Lond) 2010, 118(Jan (2)):99-113.
25. Timmons B.W., Hamadeh M.J., Devries M.C., Tarnopolsky M.A. Influence of gender, menstrual phase, and oral contraceptive use on immunological changes in response to prolonged cycling. J Appl Physiol (1985) 2005, 99(Sep (3)):979-985.
26. Navalta J.W., Sedlock D.A., Park K.S., McFarlin B.K. Neither gender nor menstrual cycle phase influences exercise-induced lymphocyte apoptosis in untrained subjects. Appl Physiol Nutr Metab 2007, 32(Jun (3)):481-486.
27. Tanriverdi F., Silveira L.F., Maccoll G.S., Bouloux P.M. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 2003, 176(3):293-304.
28. Bouman A., Moes H., Heineman M.J., de Leij L.F., Faas M.M. The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin. Fertil Steril 2001, 76(Sep (3)):555-559.